Benefits of PresVu Eye Drops for Presbyopia Treatment
Entod Pharmaceuticals' "PresVu" eye drops have been approved by the Drugs Controller General of India (DCGI) as a breakthrough treatment for presbyopia.
Presbyopia is an age-related condition that affects near vision, typically occurring in people over the age of 40.
The Subject Expert Committee of the Central Drugs Standard Control Organization (CDSCO) has also approved PresVu for use.
PresVu is the first eye drop in India specifically designed to treat presbyopia, providing an alternative to reading glasses.
It is estimated that 1.09 to 1.80 billion people worldwide suffer from presbyopia, highlighting its widespread impact.
Entod Pharmaceuticals developed PresVu after years of research and development, aiming to revolutionize eye care in India.
The company has applied for a patent for PresVu's unique formulation and process.
PresVu not only improves near vision but also lubricates the eyes, providing extra comfort for patients.
The formula uses dynamic buffer technology, allowing it to adapt to the pH of tears and remain effective for a longer period.
PresVu enhances near vision within 15 minutes of application, providing quick relief for patients.
The eye drops can significantly enhance the quality of life by enabling people to perform daily tasks more easily.
Ophthalmologists like Dr. Tatyarao Rhane praised PresVu for its clinical potential in improving vision without the need for reading glasses.